Posted in | News | Laser | Imaging | Medical Optics

Imaging Diagnostic Systems Announces Order for CTLM System in Malaysia and Indonesia

Imaging Diagnostic Systems, Inc., (OTCBB:IMDS) a pioneer in laser optical breast imaging systems, announced today that it has received a deposit for its second CTLM® system for Malaysia and a purchase order for a system to be installed in Indonesia.

CTLM Laser Breast Imaging

The systems will be delivered in January 2010; installation and training will commence immediately upon delivery.

The orders were placed through Jainsons PTY LTD., a distribution company based in Perth, Australia that serves as IDSI’s distributor for the CTLM system in Australia and Southeast Asia. Established in 1996 to distribute medical equipment in Southeast Asia, Jainsons represents U.S.-based medical companies that have developed innovative medical products and laser technologies.

“With a second CTLM system in Malaysia and one in Indonesia, we will be able to bring laser breast imaging technology to the women in Southeast Asia, especially for younger women or those with dense breast tissue,” stated Dr. Mukesh Jain, Jainsons’ Chairman and CEO.

Dr. Jain, who has been personally involved in the distribution of medical products for over twenty years, has developed a strong network and established key relationships with principals of medical companies throughout his career, as well as with agents throughout the region.

Source: http://www.imds.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.